Intrinsiqs

Is Champions Oncology, Inc. overvalued?

Champions Oncology, Inc. (CSBR) — key valuation metrics and fundamentals.

No verdict
Price
$4.93
Fair value
—
Current P/E
—
Normal P/E
19.7
Market cap
$68.5M
Dividend yield
0.0%
Return on equity
-27.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CSBR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.